About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Smad1tm2Rob
targeted mutation 2, Elizabeth J Robertson
MGI:2155484
Summary 9 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Ltftm1(icre)Tdku/Ltf+
Smad1tm2Rob/Smad1tm2Rob
Smad5tm1Huy/Smad5tm1Huy
involves: 129P2/OlaHsd * 129S/SvEv * 129S6/SvEvTac * C57BL/6 MGI:7287387
cn2
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2Rob
Smad5tm1Huy/Smad5tm1Zuk
involves: 129P2/OlaHsd * 129S/SvEv * 129S7/SvEvBrd * C57BL/6 MGI:3769366
cn3
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2.1Rob
Smad5tm1Huy/Smad5tm1Huy
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 MGI:3769364
cn4
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2Rob
Smad5tm1Huy/Smad5tm1Zuk
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J MGI:4437297
cn5
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2Rob
Smad5tm1Huy/Smad5tm1Huy
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J MGI:4437295
cn6
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2.1Rob
Smad5tm1Huy/Smad5tm1Huy
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J MGI:4437296
cn7
Meox2tm1(cre)Sor/Meox2+
Smad1tm2Rob/Smad1tm2Sor
involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 MGI:4437795
cn8
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2Rob
Smad5tm1Huy/Smad5tm1Zuk
Smad9tm1Jfm/Smad9tm1Jfm
involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 MGI:3769375
cn9
Ltftm1(icre)Tdku/Ltf+
Smad1tm2Rob/Smad1tm2Rob
involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6 MGI:7287384


Genotype
MGI:7287387
cn1
Allelic
Composition
Ltftm1(icre)Tdku/Ltf+
Smad1tm2Rob/Smad1tm2Rob
Smad5tm1Huy/Smad5tm1Huy
Genetic
Background
involves: 129P2/OlaHsd * 129S/SvEv * 129S6/SvEvTac * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ltftm1(icre)Tdku mutation (1 available); any Ltf mutation (40 available)
Smad1tm2Rob mutation (1 available); any Smad1 mutation (32 available)
Smad5tm1Huy mutation (0 available); any Smad5 mutation (23 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
N
• females treated with estrogen at P21 and P22 (to increase Ltf-icre activity) show no defects in endometrial gland morphology or stromal cell compartments in the uterus at 16 weeks of age
• females failed to produce any litters in month 5 or 6 of the breeding trial, indicating a gradual decline in fertility
• at 6.5 dpc, the pregnancy rate is significantly lower than that in control females (12.5% versus 88.9%, respectively)
• at 5.5 dpc, the extent of decidual development and decidual pSMAD1/5 expression are reduced in the implantation sites
• after induction of artificial decidualization, the ratio of the decidual to non-decidual uterine horn weight is significantly lower than that in controls, indicating defective stromal cell decidualization
• at 4.5 dpc, unattached blastocysts are detected in the uterus
• delayed embryo implantation appears to cause a subsequent cascade of defects that results in early pregnancy losses
• at 4.5 dpc, females show a wide range of implantation defects, including loosely attached/floating blastocysts, decreased PTGS2 (aka COX2) expression, FOXO1 cytoplasmic mislocalization, and retained PR expression in the luminal uterine epithelium
• ~50% of females exhibit no implantation sites at 4.5 dpc, as detected by blue dye injection
• at 5.5 dpc, implantation sites show various morphological and molecular defects
• at 6.5 dpc, the number of implantation sites is decreased, and the few sites observed are smaller, appear to be growth restricted, and show reduced decidual development
• at 3.5 dpc, the luminal uterine epithelium continues to proliferate and shows prominent Ki67 staining, increased MUC1 expression and enhanced E2-response, indicating a non-receptive state
• defective expression of various histological and molecular markers of endometrial receptivity is observed at 4.5 dpc
• females failed to deliver any pups after the third month of the 6-mo fertility trial
• 4 of 7 females lost the ability to produce pups after the first litter
• when 6-wk-old females (pretreated with estrogen at P21 and P22 to increase Ltf-icre activity) are mated with wild-type males, the total number of cumulative pups obtained over a 6-mo fertility trial is significantly lower than that in controls (35 versus 201 pups, respectively), indicating severe subfertility
• over the course of the trial, the number of pups per female is significantly lower than that in control females (5.13 +/- 3.56 versus 29.13 +/- 9.15 pups/female, respectively)
• however, the number of blastocysts collected at 3.5 dpc is not altered, indicating normal ovarian and oviductal function
• over the course of a 6-mo fertility trial, number of pups per litter is significantly lower than that in control females (2.85 +/- 1.86 versus 6.61 +/- 1.55 pups/litter, respectively)

embryo
• endometrial receptivity and implantation defects result in impaired decidual and embryonic development at 5.5 dpc and 6.5 dpc
• at 5.5 dpc, the extent of decidual development and decidual pSMAD1/5 expression are reduced in the implantation sites
• after induction of artificial decidualization, the ratio of the decidual to non-decidual uterine horn weight is significantly lower than that in controls, indicating defective stromal cell decidualization

mortality/aging
• females failed to produce any litters in month 5 or 6 of the breeding trial, indicating a gradual decline in fertility




Genotype
MGI:3769366
cn2
Allelic
Composition
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2Rob
Smad5tm1Huy/Smad5tm1Zuk
Genetic
Background
involves: 129P2/OlaHsd * 129S/SvEv * 129S7/SvEvBrd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Amhr2tm3(cre)Bhr mutation (1 available); any Amhr2 mutation (27 available)
Smad1tm2Rob mutation (1 available); any Smad1 mutation (32 available)
Smad5tm1Huy mutation (0 available); any Smad5 mutation (23 available)
Smad5tm1Zuk mutation (1 available); any Smad5 mutation (23 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• female mice become infertile after 3 to 4 months of breeding

reproductive system
• after 3 months of age, 100% of female mice have unilateral or bilateral ovarian tumors
• over 70% of female mice have metastic ovarian cancer by 1 year of age
• 100% of male mice by 7 months of age exhibit tumors in the testis
• early stage tumors appear to be sex cord stromal tumors with Sertoli and Leydig cell differentiation
• female mice become infertile after 3 to 4 months of breeding
• slight infertility, with a 16% decrease in litters per month when bred to wild-type females

neoplasm
• after 3 months of age, 100% of female mice have unilateral or bilateral ovarian tumors
• over 70% of female mice have metastic ovarian cancer by 1 year of age
• 100% of male mice by 7 months of age exhibit tumors in the testis
• early stage tumors appear to be sex cord stromal tumors with Sertoli and Leydig cell differentiation

cardiovascular system
• found in 50% of female mice over 9 months in age
• found in about 60% of male mice by 11 months in age

endocrine/exocrine glands
• after 3 months of age, 100% of female mice have unilateral or bilateral ovarian tumors
• over 70% of female mice have metastic ovarian cancer by 1 year of age
• 100% of male mice by 7 months of age exhibit tumors in the testis
• early stage tumors appear to be sex cord stromal tumors with Sertoli and Leydig cell differentiation




Genotype
MGI:3769364
cn3
Allelic
Composition
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2.1Rob
Smad5tm1Huy/Smad5tm1Huy
Genetic
Background
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Amhr2tm3(cre)Bhr mutation (1 available); any Amhr2 mutation (27 available)
Smad1tm2.1Rob mutation (0 available); any Smad1 mutation (32 available)
Smad1tm2Rob mutation (1 available); any Smad1 mutation (32 available)
Smad5tm1Huy mutation (0 available); any Smad5 mutation (23 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• female mice become infertile after 3 to 4 months of breeding

reproductive system
• after 3 months of age, 100% of female mice have unilateral or bilateral ovarian tumors
• over 70% of female mice have metastic ovarian cancer by 1 year of age
• 100% of male mice by 7 months of age exhibit tumors in the testis
• early stage tumors appear to be sex cord stromal tumors with Sertoli and Leydig cell differentiation
• female mice become infertile after 3 to 4 months of breeding
• slight infertility, with a 16% decrease in litters per month when bred to wild-type females

neoplasm
• after 3 months of age, 100% of female mice have unilateral or bilateral ovarian tumors
• over 70% of female mice have metastic ovarian cancer by 1 year of age
• 100% of male mice by 7 months of age exhibit tumors in the testis
• early stage tumors appear to be sex cord stromal tumors with Sertoli and Leydig cell differentiation

cardiovascular system
• found in 50% of female mice over 9 months in age
• found in about 60% of male mice by 11 months in age

endocrine/exocrine glands
• after 3 months of age, 100% of female mice have unilateral or bilateral ovarian tumors
• over 70% of female mice have metastic ovarian cancer by 1 year of age
• 100% of male mice by 7 months of age exhibit tumors in the testis
• early stage tumors appear to be sex cord stromal tumors with Sertoli and Leydig cell differentiation




Genotype
MGI:4437297
cn4
Allelic
Composition
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2Rob
Smad5tm1Huy/Smad5tm1Zuk
Genetic
Background
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Amhr2tm3(cre)Bhr mutation (1 available); any Amhr2 mutation (27 available)
Smad1tm2Rob mutation (1 available); any Smad1 mutation (32 available)
Smad5tm1Huy mutation (0 available); any Smad5 mutation (23 available)
Smad5tm1Zuk mutation (1 available); any Smad5 mutation (23 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 33% of mutant females survived to 32 weeks
• 50% survival at approximately 29 week of age

neoplasm
• develop granulosa cell tumors early during sexual maturity (at least by 8 wk of age)
• tumor characteristic: lacked nuclear grooves, infrequently contained Call-Exner bodies, high mitotic index, increased serum Inhibin A and anti-Mullerian hormone (AMH) level
• AMH expression in primary tumors and tumor cells as they metastasize outside the ovary

homeostasis/metabolism

endocrine/exocrine glands
• develop granulosa cell tumors early during sexual maturity (at least by 8 wk of age)
• tumor characteristic: lacked nuclear grooves, infrequently contained Call-Exner bodies, high mitotic index, increased serum Inhibin A and anti-Mullerian hormone (AMH) level
• AMH expression in primary tumors and tumor cells as they metastasize outside the ovary

reproductive system
• develop granulosa cell tumors early during sexual maturity (at least by 8 wk of age)
• tumor characteristic: lacked nuclear grooves, infrequently contained Call-Exner bodies, high mitotic index, increased serum Inhibin A and anti-Mullerian hormone (AMH) level
• AMH expression in primary tumors and tumor cells as they metastasize outside the ovary

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
ovarian cancer DOID:2394 OMIM:167000
OMIM:607893
J:157310




Genotype
MGI:4437295
cn5
Allelic
Composition
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2Rob
Smad5tm1Huy/Smad5tm1Huy
Genetic
Background
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Amhr2tm3(cre)Bhr mutation (1 available); any Amhr2 mutation (27 available)
Smad1tm2Rob mutation (1 available); any Smad1 mutation (32 available)
Smad5tm1Huy mutation (0 available); any Smad5 mutation (23 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 33% of mutant females survived to 32 weeks
• 50% survival at approximately 29 week of age

neoplasm
• develop granulosa cell tumors early during sexual maturity (at least by 8 wk of age)
• tumor characteristic: lacked nuclear grooves, infrequently contained Call-Exner bodies, high mitotic index, increased serum Inhibin A and anti-Mullerian hormone (AMH) level
• AMH expression in primary tumors and tumor cells as they metastasize outside the ovary

homeostasis/metabolism

endocrine/exocrine glands
• develop granulosa cell tumors early during sexual maturity (at least by 8 wk of age)
• tumor characteristic: lacked nuclear grooves, infrequently contained Call-Exner bodies, high mitotic index, increased serum Inhibin A and anti-Mullerian hormone (AMH) level
• AMH expression in primary tumors and tumor cells as they metastasize outside the ovary

reproductive system
• develop granulosa cell tumors early during sexual maturity (at least by 8 wk of age)
• tumor characteristic: lacked nuclear grooves, infrequently contained Call-Exner bodies, high mitotic index, increased serum Inhibin A and anti-Mullerian hormone (AMH) level
• AMH expression in primary tumors and tumor cells as they metastasize outside the ovary

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
ovarian cancer DOID:2394 OMIM:167000
OMIM:607893
J:157310




Genotype
MGI:4437296
cn6
Allelic
Composition
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2.1Rob
Smad5tm1Huy/Smad5tm1Huy
Genetic
Background
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Amhr2tm3(cre)Bhr mutation (1 available); any Amhr2 mutation (27 available)
Smad1tm2.1Rob mutation (0 available); any Smad1 mutation (32 available)
Smad1tm2Rob mutation (1 available); any Smad1 mutation (32 available)
Smad5tm1Huy mutation (0 available); any Smad5 mutation (23 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 33% of mutant females survived to 32 weeks
• 50% survival at approximately 29 week of age

neoplasm
• develop granulosa cell tumors early during sexual maturity (at least by 8 wk of age)
• tumor characteristic: lacked nuclear grooves, infrequently contained Call-Exner bodies, high mitotic index, increased serum Inhibin A and anti-Mullerian hormone (AMH) level
• AMH expression in primary tumors and tumor cells as they metastasize outside the ovary

homeostasis/metabolism

endocrine/exocrine glands
• develop granulosa cell tumors early during sexual maturity (at least by 8 wk of age)
• tumor characteristic: lacked nuclear grooves, infrequently contained Call-Exner bodies, high mitotic index, increased serum Inhibin A and anti-Mullerian hormone (AMH) level
• AMH expression in primary tumors and tumor cells as they metastasize outside the ovary

reproductive system
• develop granulosa cell tumors early during sexual maturity (at least by 8 wk of age)
• tumor characteristic: lacked nuclear grooves, infrequently contained Call-Exner bodies, high mitotic index, increased serum Inhibin A and anti-Mullerian hormone (AMH) level
• AMH expression in primary tumors and tumor cells as they metastasize outside the ovary

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
ovarian cancer DOID:2394 OMIM:167000
OMIM:607893
J:157310




Genotype
MGI:4437795
cn7
Allelic
Composition
Meox2tm1(cre)Sor/Meox2+
Smad1tm2Rob/Smad1tm2Sor
Genetic
Background
involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Meox2tm1(cre)Sor mutation (3 available); any Meox2 mutation (18 available)
Smad1tm2Rob mutation (1 available); any Smad1 mutation (32 available)
Smad1tm2Sor mutation (1 available); any Smad1 mutation (32 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 24% of pups die at birth

digestive/alimentary system
• in severely affected newborns, the stomach is ruptured
• the stomach epithelium is very thin
• the muscular layer of the stomach is almost completely absent
• bloated stomach with accumulation of air in the abdomen

growth/size/body
• bloated stomach with accumulation of air in the abdomen

muscle
• the muscular layer of the stomach is almost completely absent




Genotype
MGI:3769375
cn8
Allelic
Composition
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2Rob
Smad5tm1Huy/Smad5tm1Zuk
Smad9tm1Jfm/Smad9tm1Jfm
Genetic
Background
involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Amhr2tm3(cre)Bhr mutation (1 available); any Amhr2 mutation (27 available)
Smad1tm2Rob mutation (1 available); any Smad1 mutation (32 available)
Smad5tm1Huy mutation (0 available); any Smad5 mutation (23 available)
Smad5tm1Zuk mutation (1 available); any Smad5 mutation (23 available)
Smad9tm1Jfm mutation (0 available); any Smad9 mutation (32 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• after 3 months of age, 100% of female mice have unilateral or bilateral ovarian tumors
• over 70% of female mice have metastic ovarian cancer by 1 year of age

mortality/aging
• female mice become infertile after 3 to 4 months of breeding

reproductive system
• after 3 months of age, 100% of female mice have unilateral or bilateral ovarian tumors
• over 70% of female mice have metastic ovarian cancer by 1 year of age
• female mice become infertile after 3 to 4 months of breeding

neoplasm
• after 3 months of age, 100% of female mice have unilateral or bilateral ovarian tumors
• over 70% of female mice have metastic ovarian cancer by 1 year of age

cardiovascular system
• found in 50% of female mice over 9 months in age




Genotype
MGI:7287384
cn9
Allelic
Composition
Ltftm1(icre)Tdku/Ltf+
Smad1tm2Rob/Smad1tm2Rob
Genetic
Background
involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ltftm1(icre)Tdku mutation (1 available); any Ltf mutation (40 available)
Smad1tm2Rob mutation (1 available); any Smad1 mutation (32 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
N
• when 6-wk-old females (pretreated with estrogen at P21 and P22 to increase Ltf-icre activity) are mated with wild-type males for 6 months, average litter size is comparable to that in controls, suggesting normal female fertility





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/07/2024
MGI 6.23
The Jackson Laboratory